Squarepoint
HRMY icon

Squarepoint’s Harmony Biosciences HRMY Stock Holding History

Squarepoint’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
39,063
-2,037
-5% -$64.3K ﹤0.01% 2603
2026
Q1 		$1.15M Buy
41,100
+2,100
+5% +$68.9K ﹤0.01% 2653
2025
Q4 		$1.46M Hold
39,000
– – ﹤0.01% 2295
2025
Q3 		$1.07M Hold
39,000
– – ﹤0.01% 2630
2025
Q2 		$1.23M Sell
39,000
-8,889
-19% -$286K ﹤0.01% 2488
2025
Q1 		$1.59M Buy
47,889
+30,988
+183% +$1.11M ﹤0.01% 2281
2024
Q4 		$582K Buy
16,901
+9,411
+126% +$323K ﹤0.01% 3606
2024
Q3 		$300K Sell
7,490
-42,527
-85% -$1.49M ﹤0.01% 3447
2024
Q2 		$1.51M Buy
+50,017
New +$1.5M ﹤0.01% 2259
2023
Q2 		– Sell
-17,339
Closed -$566K – 3745
2023
Q1 		$566K Sell
17,339
-60,623
-78% -$2.76M ﹤0.01% 2232
2022
Q4 		$4.3M Buy
77,962
+30,783
+65% +$1.69M 0.02% 917
2022
Q3 		$2.09M Buy
47,179
+11,112
+31% +$542K 0.01% 1296
2022
Q2 		$1.76M Sell
36,067
-13,904
-28% -$626K 0.01% 1279
2022
Q1 		$2.43M Buy
49,971
+10,720
+27% +$437K 0.01% 1043
2021
Q4 		$1.67M Buy
+39,251
New +$1.56M ﹤0.01% 1365
2021
Q3 		– Sell
-38,041
Closed -$1.07M – 3135
2021
Q2 		$1.07M Buy
+38,041
New +$1.14M ﹤0.01% 1576
2020
Q4 		– Sell
-10,461
Closed -$355K – 3058
2020
Q3 		$355K Buy
+10,461
New +$381K ﹤0.01% 1677

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's HRMY Position: Q2 2026 in Review

Squarepoint reduced its Harmony Biosciences (HRMY) stake by 5% in Q2 2026, selling an estimated $64.3K and leaving 39,063 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Squarepoint first reported a position in HRMY in Q3 2020 and has held it in 17 quarters since. The position peaked at $4.3M in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Squarepoint held 39,063 shares of Harmony Biosciences worth $1.42M as of Q2 2026.
  • Squarepoint sold 2,037 Harmony Biosciences shares in Q2 2026, an estimated $64.3K.
  • Harmony Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2603 holding.
  • Squarepoint first reported a position in Harmony Biosciences in Q3 2020 and has held it in 17 quarters since.
  • Squarepoint's Harmony Biosciences position peaked at $4.3M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.